These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3498760)

  • 1. Hyperthyroxinemic mice have reduced natural killer cell activity. Evidence for a defective trigger mechanism.
    Stein-Streilein J; Zakarija M; Papic M; McKenzie JM
    J Immunol; 1987 Oct; 139(7):2502-7. PubMed ID: 3498760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B; Katz J; Gottlieb M
    J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
    Graves SS; Bramhall J; Bonavida B
    J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of spleen cell natural killer activity by thyroid hormone treatment in old mice.
    Provinciali M; Muzzioli M; Di Stefano G; Fabris N
    Nat Immun Cell Growth Regul; 1991; 10(4):226-36. PubMed ID: 1716738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
    Hackett J; Bennett M; Kumar V
    J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "lazy" NK cells of Chediak-Higashi syndrome.
    Targan SR; Oseas R
    J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroxine-dependent modulation of natural killer activity.
    Provinciali M; Muzzioli M; Fabris N
    J Exp Pathol; 1987; 3(4):617-22. PubMed ID: 2457668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of natural killer cell activity in infant mice occurs after target cell binding.
    Dussault I; Miller SC
    Nat Immun; 1995; 14(1):35-43. PubMed ID: 7599460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells.
    Kalland T; Forsberg JG
    J Natl Cancer Inst; 1983 Aug; 71(2):385-90. PubMed ID: 6576196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of glucocorticoid action on murine natural killer cell activity.
    Cox WI; Holbrook NJ; Friedman H
    J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of peripheral blood natural killer cell activity by excess thyroid hormone.
    Papic M; Stein-Streilein J; Zakarija M; McKenzie JM; Guffee J; Fletcher MA
    J Clin Invest; 1987 Feb; 79(2):404-8. PubMed ID: 3492513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
    Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
    J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of NKCF-like activity in mixed lymphocyte-tumor cell culture: direct involvement of mycoplasma infection of tumor cells.
    Wayner EA; Brooks CG
    J Immunol; 1984 Apr; 132(4):2135-42. PubMed ID: 6230401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.